Upload

Loading...

This video is unavailable.

Alzheimer's Prevention Trial - A Unique Patient Population

Like this video?

Sign in to make your opinion count.

Don't like this video?

Sign in to make your opinion count.

Want to watch this again later?

Sign in to add this video to a playlist.

Published on May 15, 2012

Genentech, the Banner Alzheimer's Institute, and the National Institutes of Health are collaborating on the first-ever prevention trial in cognitively healthy individuals who are likely to develop Alzheimer's disease due to their genetic history. In this video, Richard Schelller, Genentech's Executive Vice President of Research and Early Development, discusses why this particular patient population is so unique and how Alzheimer's has had an impact on their lives.

Loading...

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading...

Suggestions

Loading...
Working...
to add this to Watch Later

Add to